Lipid transfer protein activities in subjects with impaired glucose tolerance

被引:10
作者
Julius, Ulrich
Jauhiainen, Matti
Ehnholm, Christian
Pietzsch, Jens
机构
[1] Univ Hosp Dresden, Med Clin, Dresden, Germany
[2] Univ Hosp Dresden, Outpatient Dept 3, Dresden, Germany
[3] Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland
[4] Inst Radiopharm, Res Ctr, Dept Radiopharmaceut Biol, Dresden, Germany
关键词
cholesterol ester transfer protein; impaired glucose tolerance; oral fat loading test; oral glucose tolerance test; phospholipid transfer protein;
D O I
10.1515/CCLM.2007.032
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Impaired glucose tolerance (IGT) is associated with an increased risk of atherosclerosis that may be due in part to dyslipidemia. The purpose of this study was to assess the regulatory role of lipid transfer proteins in the development of this dyslipidemia. Methods: Activities of cholesterol ester transfer protein (CETP) and phospholipid transfer protein (PLTP), as well as lipid and protein components of the major lipoprotein fractions, were evaluated in probands with IGT and were compared with those in subjects with normal glucose tolerance. The effect of a fat-rich meal on these variables was also investigated. Results: IGT probands had a higher triglyceride content in subfractions of low-(LDL) and high-density lipoprotein (HDL). IGT patients had higher fasting CETP activity. The latter was positively correlated with HDL2 triglycerides and negatively with HDL3 total cholesterol. PLTP activity and mass were not higher in IGT patients. However, PLTP activity correlated with components of VLDL and LDL and was influenced by the type of obesity. Neither CETP and PLTP activities nor PLTP mass were altered by a fat-rich meal. PLTP and CETP activities correlated in both fasting and postprandial conditions. Conclusions: Increased fasting CETP activity may contribute to increased risk of atherosclerosis in subjects with IGT. Clin Chem Lab Med 2007;45:237-43.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 48 条
[1]   Emerging roles for phospholipid transfer protein in lipid and lipoprotein metabolism [J].
Albers, JJ ;
Cheung, MC .
CURRENT OPINION IN LIPIDOLOGY, 2004, 15 (03) :255-260
[2]   LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects [J].
Ambrosch, A ;
Muhlen, I ;
Kopf, D ;
Augustin, W ;
Dierkes, J ;
König, W ;
Luley, C ;
Lehnert, H .
DIABETES CARE, 1998, 21 (12) :2077-2084
[3]   Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease [J].
Barter, PJ ;
Kastelein, JJP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (03) :492-499
[4]   Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin : cholesterol acyltransferase and lipid transfer proteins [J].
Borggreve, SE ;
de Vries, R ;
Dullaart, RPF .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (12) :1051-1069
[5]   Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport [J].
Bruce, C ;
Chouinard, RA ;
Tall, AR .
ANNUAL REVIEW OF NUTRITION, 1998, 18 :297-330
[6]   Impaired glucose tolerance and cardiovascular disease: The possible role of post-prandial hyperglycemia [J].
Ceriello, A .
AMERICAN HEART JOURNAL, 2004, 147 (05) :803-807
[7]   Association of plasma phospholipid transfer protein activity with IDL and buoyant LDL: impact of gender and adiposity [J].
Cheung, MC ;
Knopp, RH ;
Retzlaff, B ;
Kennedy, H ;
Wolfbauer, G ;
Albers, JJ .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (01) :53-59
[8]   Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B - Containing lipoproteins in subjects with and without type 1 diabetes [J].
Colhoun, HM ;
Taskinen, MR ;
Otvos, JD ;
van den Berg, P ;
O'Connor, J ;
Van Tol, A .
DIABETES, 2002, 51 (11) :3300-3305
[9]   Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells [J].
Desrumaux, CM ;
Mak, PA ;
Boisvert, WA ;
Masson, D ;
Stupack, D ;
Jauhiainen, M ;
Ehnholm, C ;
Curtiss, LK .
JOURNAL OF LIPID RESEARCH, 2003, 44 (08) :1453-1461
[10]   Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations [J].
Dullaart, RPF ;
De Vries, R ;
Scheek, L ;
Borggreve, SE ;
Van Gent, T ;
Dallinga-Thie, GM ;
Ito, M ;
Nagano, M ;
Sluiter, WJ ;
Hattori, H ;
Van Tol, A .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2004, 64 (03) :205-215